Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Prevention of Bone Metastasis in Advanced Lung Cancer
NCT02622607Phase 3Unknown
- Sponsor
- Tangdu Hospital
- Start
- Jan 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in lung cancer, sponsored by Tangdu Hospital. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT02622607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622607.